A study on influencers of total sales revenue of generic pharmaceutical companies in Indonesia

Destrina Grace Simanjuntak and Raymond Tjandrawinata ()

MPRA Paper from University Library of Munich, Germany

Abstract: This paper empirically examines the influence of firms’ one-year lagged of total new products (t-1), one-year lagged profitability (t-1), and market share of new products to firms’ amount of sales revenue in pharmaceutical generic companies in Indonesia. The data used in this study was panel dataset, gathered from six large pharmaceutical generic companies in Indonesia, during the period 2006 to 2010. The regression analysis method uses fixed effect models, with generalized least squares (GLS) method. The result shows that firms’ one-year lagged of total new product (t-1), one-year lagged profitability (t-1), and market share of new products to be positive and affect significantly the firms’ sales revenue in the pharmaceutical generic companies in Indonesia.

Keywords: Pharmaceutical Generic Companies; Profitability; New Generic Product; Market Share; Sales Revenue (search for similar items in EconPapers)
JEL-codes: A10 C23 G30 L21 M21 (search for similar items in EconPapers)
Date: 2011-06-17
New Economics Papers: this item is included in nep-mkt and nep-sea
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://mpra.ub.uni-muenchen.de/31628/4/MPRA_paper_31628.pdf original version (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:31628

Access Statistics for this paper

More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter ().